Evidence map›Paper›PMID 40156166›Full record

ArticleThe British journal of surgery2025

Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study.

Sander J M van Hootegem, Margrietha van der Linde, Marcel A Schneider, Jeesun Kim, Felix Berlth, Yutaka Sugita, Peter P Grimminger, Gian Luca Baiocchi, Giovanni De Manzoni, Maria Bencivenga and 9 more

Abstract readMulticenter Study
In one paragraph

Article in The British journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sander J M van HootegemDepartment of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0002-0220-028X
Margrietha van der LindeDepartment of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands.
Marcel A SchneiderDepartment of Surgery & Transplantation, University Hospital Zürich, Zürich, Switzerland.ORCID 0000-0002-6723-8879
Jeesun KimDepartment of Surgery, Seoul National University Cancer Hospital, Seoul, Korea.
Felix BerlthDepartment of General, Visceral and Transplant Surgery, University Medical Centre Mainz, Mainz, Germany.
Yutaka SugitaDepartment of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Peter P GrimmingerDepartment of General, Visceral and Transplant Surgery, University Medical Centre Mainz, Mainz, Germany.ORCID 0000-0002-1859-9213
Gian Luca BaiocchiDepartment of Surgery, University Hospital of Brescia, Brescia, Italy.ORCID 0000-0003-2402-2178
Giovanni De ManzoniDepartment of Surgery, University Hospital of Verona, Verona, Italy.
Maria BencivengaDepartment of Surgery, University Hospital of Verona, Verona, Italy.
Suzanne GisbertzDepartment of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Souya NunobeDepartment of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID 0000-0003-3012-5632
Han-Kwang YangDepartment of Surgery, Seoul National University Cancer Hospital, Seoul, Korea.ORCID 0000-0003-3495-3048
Christian A GutschowDepartment of Surgery & Transplantation, University Hospital Zürich, Zürich, Switzerland.ORCID 0000-0001-6171-4427
Sjoerd M LagardeDepartment of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.
Hester F LingsmaDepartment of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands.
Bas P L WijnhovenDepartment of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0003-4738-3697
GastroBenchmark Consortium
GASTRODATA Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo reduce the clinical and economic burden of complications after gastrectomy for gastric cancer, specific complications should be targeted to effectively allocate healthcare resources for quality improvement and preventive measures. The aim of this study was to assess the impact of complications on clinical outcomes.

methodsThis was a retrospective multicentre study of patients who underwent (sub)total gastrectomy for gastric or junctional adenocarcinoma at 43 centres in 16 countries between 2017 and 2021. Outcomes were escalation of care, reoperation, prolonged hospital stay (greater than the 75th percentile), readmission, and 30-day mortality. Adjusted relative risks and population attributable fractions were estimated for specific complication-outcome pairs. The population attributable fraction represents the percentage reduction in the frequency of an adverse outcome if a complication could be completely prevented in the population.

resultsIn total, 7829 patients were included. Postoperative complications occurred in 1884 patients (24.1%). The most frequent complications were pulmonary complications (436 patients (5.6%)), anastomotic leakage (363 patients (4.6%)), and abdominal collection (301 patients (3.8%)). Anastomotic leakage, cardiac complications, and pulmonary complications had the greatest impact on 30-day mortality (population attributable fraction 26.6% (95% c.i. 14.5% to 38.6%), 18.7% (95% c.i. 9.4% to 28.0%), and 15.6% (95% c.i. 12.0% to 30.0%) respectively). Anastomotic leakage and pulmonary complications had the greatest impact on escalation of care (population attributable fraction 26.3% (95% c.i. 20.6% to 32.0%) and 18.4% (95% c.i. 11.7% to 25.2%) respectively), whereas anastomotic leakage and intra-abdominal bleeding had the greatest impact on reoperation (population attributable fraction 31.6% (95% c.i. 26.4% to 36.9%) and 8.5% (95% c.i. 5.5% to 11.5%) respectively). Most of the studied complications contributed to a prolonged hospital stay, whereas the contribution of complications to readmission did not exceed 15.9%. Subgroup analysis showed regional variation in the impact of complications.

conclusionAnastomotic leakage had the largest overall negative impact on clinical outcomes after gastrectomy for gastric adenocarcinoma. Reducing the incidence of anastomotic leakage and pulmonary complications would have the most impact on the burden of complications.

Indexed as

AdenocarcinomaGastrectomyPostoperative ComplicationsStomach NeoplasmsAgedAged, 80 and overFemaleHumansLength of StayMaleMiddle AgedPatient ReadmissionReoperationRetrospective StudiesTreatment Outcome

Identifiers

PMID40156166
PMCPMC11953074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.